Can Prime Medicine Inc’s (PRME) hike of 4.28% in a week be considered a lucky break?

On November 20, 2023, Prime Medicine Inc (NASDAQ: PRME) opened at $6.65, higher 5.30% from the last session. During the day, the shares moved up to $7.46 and dropped to $6.53 before settling in for the closing price of $6.60. Price fluctuations for PRME have ranged from $5.54 to $21.48 over the past 52 weeks.

Elon Musk just Triggered a BOOM in These Stocks

Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"

Click Here to Download the FREE Report.


Annual sales at Healthcare sector company slipped by -33.33% over the past five years. Company’s average yearly earnings per share was noted 55.22% at the time writing. With a float of $33.53 million, this company’s outstanding shares have now reached $97.21 million.

Let’s look at the performance matrix of the company that is accounted for 175 employees.

Prime Medicine Inc (PRME) Insider and Institutional Ownership

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Prime Medicine Inc is 65.55%, while institutional ownership is 27.87%. The most recent insider transaction that took place on Jun 21, was worth 284,496. In this transaction 10% Owner of this company sold 19,003 shares at a rate of $14.97, taking the stock ownership to the 0 shares. Before that another transaction happened on Jun 20, when Company’s 10% Owner sold 37,405 for $15.06, making the entire transaction worth $563,248. This insider now owns 0 shares in total.

Prime Medicine Inc (PRME) Latest Financial update

If we go through the results of last quarter, which was made public on 9/29/2023, the company posted -$0.55 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.46) by -$0.09. This company achieved a return on equity of -43.83. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.5 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 55.22% per share during the next fiscal year.

Prime Medicine Inc (NASDAQ: PRME) Trading Performance Indicators

Check out the current performance indicators for Prime Medicine Inc (PRME). In the past quarter, the stock posted a quick ratio of 4.69.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.88, a number that is poised to hit -0.45 in the next quarter and is forecasted to reach -1.77 in one year’s time.

Technical Analysis of Prime Medicine Inc (PRME)

Prime Medicine Inc (NASDAQ: PRME) saw its 5-day average volume 0.91 million, a positive change from its year-to-date volume of 0.34 million. As of the previous 9 days, the stock’s Stochastic %D was 21.92%. Additionally, its Average True Range was 0.73.

During the past 100 days, Prime Medicine Inc’s (PRME) raw stochastic average was set at 13.81%, which indicates a significant decrease from 34.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 114.11% in the past 14 days, which was higher than the 77.21% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $8.38, while its 200-day Moving Average is $12.80. Nevertheless, the first resistance level for the watch stands at $7.43 in the near term. At $7.91, the stock is likely to face the second major resistance level. The third major resistance level sits at $8.36. If the price goes on to break the first support level at $6.50, it is likely to go to the next support level at $6.05. The third support level lies at $5.57 if the price breaches the second support level.

Prime Medicine Inc (NASDAQ: PRME) Key Stats

There are currently 97,324K shares outstanding in the company with a market cap of 676.37 million. Presently, the company’s annual sales total 0 K according to its annual income of -121,820 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -50,710 K.


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...



Don't miss

Wearable Devices (WLDS) Stock Rose 12% On Tuesday, But On What Basis?

Wearable Devices Ltd (NASD: WLDS) is experiencing significant growth...

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Rocket Pharmaceuticals Inc (RCKT) surge 12.73% in a week: will this be a lucky break through?

Rocket Pharmaceuticals Inc (NASDAQ: RCKT) started the day on December 07, 2023, with a price increase of 1.82% at $26.30. During the day, the...

California Resources Corporation (CRC) Open at price of $49.34: A Brand-New Opportunity for Investors

California Resources Corporation (NYSE: CRC) open the trading on December 07, 2023, with a bit cautious approach as it glided -0.14% to $49.12. During...

Wayfair Inc (W) Open at price of $52.35: A Brand-New Opportunity for Investors

Witnessing the stock’s movement on the chart, on December 07, 2023, Wayfair Inc (NYSE: W) remained unchanged to $53.07. During the day, the stock...


Please enter your comment!
Please enter your name here